Global Blood Therapeutics, Inc.
GBT · NASDAQ
6/30/2022 | 3/31/2022 | 12/31/2021 | 9/30/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$82 | -$81 | -$88 | -$71 |
| Dep. & Amort. | $2 | $2 | $2 | $2 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $20 | $19 | $19 | $18 |
| Change in WC | $17 | -$14 | -$3 | -$15 |
| Other Non-Cash | -$1 | $2 | $1 | $0 |
| Operating Cash Flow | -$44 | -$72 | -$68 | -$65 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$1 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$164 | -$222 | -$20 | -$31 |
| Inv. Sales/Matur. | $30 | $0 | $3 | $15 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$135 | -$223 | -$18 | -$16 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $48 | $0 | $2 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $49 | $2 | $387 | $45 |
| Financing Cash Flow | $49 | $2 | $387 | $45 |
| Forex Effect | -$0 | -$0 | $0 | -$0 |
| Net Chg. in Cash | -$131 | -$293 | $302 | -$36 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $394 | $687 | $385 | $422 |
| End Cash | $264 | $394 | $687 | $385 |
| Free Cash Flow | -$45 | -$72 | -$69 | -$66 |